icad (ICAD) Competitors $3.81 +0.08 (+2.14%) As of 01:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICAD vs. TMCI, OM, NPCE, CLPT, NNOX, SKIN, ZIMV, BSGM, SNWV, and DRTSShould you be buying icad stock or one of its competitors? The main competitors of icad include Treace Medical Concepts (TMCI), Outset Medical (OM), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. icad vs. Its Competitors Treace Medical Concepts Outset Medical NeuroPace ClearPoint Neuro Nano-X Imaging Beauty Health ZimVie Biosig Technologies Sanuwave Health Alpha Tau Medical icad (NASDAQ:ICAD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations. Does the media refer more to ICAD or TMCI? In the previous week, icad had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 4 mentions for icad and 3 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.93 beat icad's score of 0.16 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment icad 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ICAD or TMCI? icad has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Do analysts prefer ICAD or TMCI? Treace Medical Concepts has a consensus price target of $10.52, suggesting a potential upside of 81.64%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than icad.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score icad 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has better valuation & earnings, ICAD or TMCI? icad has higher earnings, but lower revenue than Treace Medical Concepts. icad is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioicad$19.61M5.34-$5.62M-$0.19-20.05Treace Medical Concepts$209.36M1.74-$55.74M-$0.85-6.81 Do insiders & institutionals hold more shares of ICAD or TMCI? 24.6% of icad shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 10.3% of icad shares are owned by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ICAD or TMCI more profitable? Treace Medical Concepts has a net margin of -25.14% compared to icad's net margin of -26.63%. icad's return on equity of -15.03% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets icad-26.63% -15.03% -11.77% Treace Medical Concepts -25.14%-48.69%-24.59% SummaryTreace Medical Concepts beats icad on 9 of the 16 factors compared between the two stocks. Get icad News Delivered to You Automatically Sign up to receive the latest news and ratings for ICAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICAD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICAD vs. The Competition Export to ExcelMetricicadCOMP IndustryComputer SectorNASDAQ ExchangeMarket Cap$104.39M$163.64B$28.18B$9.30BDividend YieldN/A1.31%3.14%4.03%P/E Ratio-20.0037.5132.9919.64Price / Sales5.3417.891,721.29188.30Price / CashN/A28.0137.6457.93Price / Book3.539.797.575.63Net Income-$5.62M$3.58B$779.73M$257.73M7 Day Performance-2.06%-1.69%-0.34%0.07%1 Month Performance-0.52%6.22%5.25%8.32%1 Year Performance178.10%43.08%52,756.65%13.78% icad Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICADicad0.6905 of 5 stars$3.81+2.1%N/A+198.4%$104.39M$19.61M-20.00140News CoverageTMCITreace Medical Concepts2.5094 of 5 stars$6.05-2.1%$10.16+67.9%-30.0%$388.66M$209.36M0.00250News CoveragePositive NewsOMOutset Medical1.7184 of 5 stars$20.45-2.2%$27.00+32.0%-71.4%$370.40M$113.69M0.00520Positive NewsAnalyst ForecastNPCENeuroPace3.5337 of 5 stars$10.22-1.6%$15.50+51.7%+21.4%$340.78M$79.91M0.00170Positive NewsCLPTClearPoint Neuro1.8195 of 5 stars$11.80+0.9%$25.00+111.9%+48.3%$327.47M$31.39M0.00110NNOXNano-X Imaging2.5708 of 5 stars$5.12-3.8%$9.50+85.5%-44.7%$307.38M$11.28M0.00190News CoveragePositive NewsAnalyst UpgradeSKINBeauty Health0.2837 of 5 stars$2.20-3.5%$1.42-35.6%-22.3%$287.27M$334.30M0.001,030ZIMVZimVie1.9935 of 5 stars$9.43-8.0%$16.33+73.2%-53.8%$285.43M$449.75M12.981,770BSGMBiosig Technologies1.8966 of 5 stars$11.55+11.0%$10.00-13.4%+955.3%$284.14M$40K0.0050News CoverageHigh Trading VolumeSNWVSanuwave HealthN/A$33.17+4.8%N/AN/A$270.79M$32.63M0.0040DRTSAlpha Tau Medical3.1265 of 5 stars$3.29+3.8%$8.00+143.2%+48.6%$268.88MN/A0.0080Positive News Related Companies and Tools Related Companies Treace Medical Concepts Alternatives Outset Medical Alternatives NeuroPace Alternatives ClearPoint Neuro Alternatives Nano-X Imaging Alternatives Beauty Health Alternatives ZimVie Alternatives Biosig Technologies Alternatives Sanuwave Health Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICAD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding icad inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share icad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICAD Stock Alerts